Cantor Fitzgerald Forecasts Strong Price Appreciation for MKS (NASDAQ:MKSI) Stock

MKS (NASDAQ:MKSI) had its target price increased by Cantor Fitzgerald from $200.00 to $300.00 in a research report issued on Tuesday, Marketbeat Ratings reports. The firm currently has an “overweight” rating on the scientific and technical instruments company’s stock. Cantor Fitzgerald’s price objective would indicate a potential upside of 42.57% from the stock’s current price.

Other equities analysts also recently issued reports about the stock. Citigroup raised their price objective on shares of MKS from $122.00 to $185.00 and gave the stock a “buy” rating in a report on Wednesday, November 12th. Wall Street Zen downgraded MKS from a “strong-buy” rating to a “buy” rating in a research report on Saturday, January 3rd. The Goldman Sachs Group lifted their price objective on MKS from $92.00 to $125.00 and gave the company a “sell” rating in a report on Thursday, October 9th. Needham & Company LLC increased their target price on shares of MKS from $170.00 to $210.00 and gave the stock a “buy” rating in a research report on Tuesday, January 13th. Finally, Bank of America upped their price objective on shares of MKS from $200.00 to $215.00 and gave the stock a “buy” rating in a research note on Tuesday, January 13th. Nine research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $198.27.

MKS Stock Up 3.2%

Shares of NASDAQ:MKSI traded up $6.43 during trading on Tuesday, reaching $210.42. 414,146 shares of the company traded hands, compared to its average volume of 946,915. The firm has a fifty day simple moving average of $163.78 and a 200 day simple moving average of $133.45. The company has a quick ratio of 1.81, a current ratio of 2.86 and a debt-to-equity ratio of 1.64. MKS has a 1-year low of $54.84 and a 1-year high of $212.16. The firm has a market cap of $14.13 billion, a P/E ratio of 51.20, a price-to-earnings-growth ratio of 1.88 and a beta of 1.92.

MKS (NASDAQ:MKSI) last announced its quarterly earnings data on Wednesday, November 5th. The scientific and technical instruments company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.80 by $0.13. MKS had a return on equity of 20.80% and a net margin of 7.25%.The business had revenue of $988.00 million during the quarter, compared to analyst estimates of $963.87 million. During the same period last year, the company earned $1.72 earnings per share. MKS’s quarterly revenue was up 10.3% compared to the same quarter last year. MKS has set its Q4 2025 guidance at 1.930-2.610 EPS. Analysts anticipate that MKS will post 6.94 earnings per share for the current fiscal year.

Insider Activity

In related news, Director Elizabeth Mora sold 300 shares of the stock in a transaction dated Tuesday, December 2nd. The shares were sold at an average price of $158.81, for a total value of $47,643.00. Following the completion of the transaction, the director owned 18,963 shares of the company’s stock, valued at approximately $3,011,514.03. This trade represents a 1.56% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.51% of the company’s stock.

Hedge Funds Weigh In On MKS

A number of institutional investors and hedge funds have recently modified their holdings of MKSI. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in MKS by 3.6% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 267,421 shares of the scientific and technical instruments company’s stock valued at $21,434,000 after buying an additional 9,170 shares during the period. Parallel Advisors LLC lifted its holdings in shares of MKS by 63.9% in the 2nd quarter. Parallel Advisors LLC now owns 952 shares of the scientific and technical instruments company’s stock worth $95,000 after acquiring an additional 371 shares during the last quarter. Assenagon Asset Management S.A. purchased a new position in shares of MKS during the 2nd quarter worth about $991,000. UMB Bank n.a. grew its holdings in MKS by 55.8% during the 2nd quarter. UMB Bank n.a. now owns 975 shares of the scientific and technical instruments company’s stock valued at $97,000 after purchasing an additional 349 shares during the last quarter. Finally, GAMMA Investing LLC raised its position in MKS by 112.7% in the 2nd quarter. GAMMA Investing LLC now owns 2,529 shares of the scientific and technical instruments company’s stock worth $251,000 after purchasing an additional 1,340 shares during the period. Hedge funds and other institutional investors own 99.79% of the company’s stock.

About MKS

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.